Naya Biosciences, Inc.
NAYA
Revenue
1.84M
▲260.31k▲16.51%
3 Months ChangeAssets
18.03M
▼-286.01k▼-1.56%
3 Months ChangeLiabilities
16.67M
▼-1.64M▼-8.95%
3 Months ChangeFree Cash Flow
-310.26k
▲1.77M▲85.11%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001493152-24-041062
2024-10-01
Form 8-K
ID: 0001493152-24-039059
2024-09-20
Form 8-K
ID: 0001493152-24-037589
2024-09-18
Form 8-K
ID: 0001493152-24-037027
2024-08-14
Form 8-K
ID: 0001493152-24-032181
2024-08-14
Form 10-Q
ID: 0001493152-24-031917
2024-07-05
Form 8-K
ID: 0001493152-24-026340
2024-06-20
Form 8-K
ID: 0001493152-24-024525
2024-05-15
Form 8-K
ID: 0001493152-24-019958
2024-05-15
Form 10-Q
ID: 0001493152-24-019786